Re-Engineering Myeloid-Mechanical Interactions in the Tumor Microenvironment to Improve Therapeutic Outcomes

Time: 2:30 pm
day: Day Two


• Leveraging RNAseq and single cell omics to identify relationships between mechanical forces in the microenvironment and cellular function

• Characterizing biophysical dynamics of the microenvironment and the impact on disease progression in glioblastoma

• Sharing proof-of-concept with a repurposed FDA-approved drug to modulate myeloid mechanics

• Discussing next steps in in identifying novel therapeutic targets and developing biophysics-based myeloid therapies